Results 181 to 190 of about 8,380 (212)
Some of the next articles are maybe not open access.

Development of a Group B Streptococcus (GBS) Cloning System

1997
In order to identify genes coding for virulence factors of GBS, a reliable method of incorporating genomic DNA into a cloning system must be developed. Most molecular technologies depend on E. coli based vector-host systems, and we describe here that these methods are unsuitable for use in cloning GBS DNA.
J P, Daniels   +3 more
openaire   +2 more sources

Temperature-Induced Self-Assembly of the Group B Streptococcus (GBS) Fusion Antigen GBS-NN

Molecular Pharmaceutics, 2018
Group B Streptococcus (GBS) is a leading cause of serious bacterial neonatal infections worldwide, which provides an unmet medical need for a globally effective vaccine. The recombinant GBS fusion antigen GBS-NN contains the N-terminal regions of the GBS Rib and Alpha C proteins.
Fabrice Rose   +7 more
openaire   +3 more sources

Prevalence and co-colonization with group b streptococcus (Gbs) Among heterosexual college couples

Annals of Epidemiology, 2000
PURPOSE: Maternal colonization with GBS is a major cause of neonatal sepsis and meningitis. While GBS transmission is assumed to be fecal-oral or person-to-person direct contact including possible sexual transmission, risk factors for colonization and carriage are poorly described.
, Manning, , Tallman, , Foxman
openaire   +2 more sources

Equivalence of high-virulence clonotypes of serotype III group B Streptococcus agalactiae (GBS)

Journal of Medical Microbiology, 2004
Analysis of growth characteristics, multilocus enzyme electrophoresis, restriction digest pattern (RDP) typing and multilocus sequence typing have identified clonotypes of serotype III group B Streptococcus agalactiae (GBS) associated with invasive infection in neonates.
Katherine E, Fleming   +4 more
openaire   +2 more sources

Antitumor effects of GBS toxin: a polysaccharide exotoxin from group B?-hemolytic streptococcus

Journal of Cancer Research and Clinical Oncology, 1993
A group B streptococcus (GBS) isolated from human neonates diagnosed with sepsis and respiratory distress ("early-onset disease") produces a polysaccharide exotoxin (GBS toxin) that, when infused in sheep, causes lung pathophysiology similar to that seen in humans.
C G, Hellerqvist   +6 more
openaire   +2 more sources

Group B streptococcus (GBS) colonisation among expectant Irish mothers.

Irish medical journal, 1998
Group B streptococci (GBS) have been recognised for more than three decades as a serious cause of perinatal morbidity and neonatal mortality. The aim of this study was to accurately determine the prevalence of GBS carriage and the serotype distribution among pregnant Irish women. 504 women attending antenatal clinics had two swabs (one perianal and one
E, Kieran   +5 more
openaire   +1 more source

[Study of carrier rate and immunity to group B streptococcus (GBS) in unmarried women].

[Nihon koshu eisei zasshi] Japanese journal of public health, 1991
In order to study the carrier rate and immunity to Group B streptococcus (GBS) of unmarried women, an urinary culture was taken and blood serum was assayed by ELISA for type-specific antibody in female students. Heretofore there have been very few reports about GBS in unmarried women in Japan. The validity of urinary culture as a substitute for vaginal
A, Sugiyama   +3 more
openaire   +1 more source

Evaluation of the Revogene® GBS DS assay performance for the intrapartum screening of group B streptococcus in comparison with intrapartum culture

Diagnostic Microbiology and Infectious Disease, 2022
Sébastien Bontems   +2 more
exaly  

Home - About - Disclaimer - Privacy